{Reference Type}: Case Reports
{Title}: Guillain-Barre syndrome after antithymocyte globulin administration in a kidney transplant recipient: A case report and literature review.
{Author}: Tavakoli F;Dalil D;Yaghoubi F;Hosseini SM;
{Journal}: Clin Case Rep
{Volume}: 11
{Issue}: 11
{Year}: 2023 Nov
暂无{DOI}: 10.1002/ccr3.8184
{Abstract}: This report describes a rare case of developing Guillain-Barre syndrome (GBS) following receiving rabbit antithymocyte globulin (ATG) after kidney transplantation to prevent acute allograft rejection in a 34-year-old man. The patient presented severe pain in the right temporomandibular joint, fever, chills, myalgia, polyarthralgia, and bone pain. Twelve hours later, he developed quadriplegia, paresthesia, and a limited range of active motions in all extremities. No antecedent viral or bacterial infection was identified. The EMG/NCV evaluation displayed acute inflammatory sensory-motor polyneuropathy. After the administration of GBS treatment, the neurologic symptoms started to improve. Over a few days, the reflexes came back completely, and the patient was able to walk. To our knowledge, this is the second case report of ATG-related GBS after kidney transplantation.